Olverembatinib Demonstrates Early Activity, Tolerability in

Olverembatinib showed antitumor activity in patients with TKI-resistant, SDH-deficient GISTs and paraganglioma.

Related Keywords

China , Guangzhou , Guangdong , Haibo Qiu , Ascentage Pharma , Sun Yat Sen University Cancer Center , ,